Quick Answer
Medicus Pharma Ltd. reported Cash and Equivalents of $8.71 million for fiscal year 2025.
Medicus Pharma Ltd. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $8.71M | +109.0% |
| 2024 | $4.16M | +142.2% |
| 2023 | $1.72M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.66M | — | -10.4% |
| June 30, 2025 | $9.67M | — | +142.8% |
| March 31, 2025 | $3.98M | — | -4.4% |
| December 31, 2024 | $4.16M | — | — |
- Medicus Pharma Ltd. showed an increase of +109.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Medicus Pharma Ltd.’s cash and equivalents has grown by 406.3% (from $1.72 million to $8.71 million).
- The most recent figure is from Medicus Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: